C1ORF74 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.019600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.778400E-01
Normal-vs-Stage2
7.126600E-01
Normal-vs-Stage3
8.499400E-01
Normal-vs-Stage4
5.175200E-01
Stage1-vs-Stage2
8.930600E-01
Stage1-vs-Stage3
3.913800E-01
Stage1-vs-Stage4
6.257000E-01
Stage2-vs-Stage3
5.687600E-01
Stage2-vs-Stage4
4.609800E-01
Stage3-vs-Stage4
4.215400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.418000E-01
Normal-vs-AfricanAmerican
1.349410E-01
Normal-vs-Asian
5.163800E-01
Caucasian-vs-AfricanAmerican
4.344600E-01
Caucasian-vs-Asian
6.103000E-01
AfricanAmerican-vs-Asian
6.788600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.102200E-01
Normal-vs-Female
6.760400E-01
Male-vs-Female
3.893000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.760200E-01
Normal-vs-Age(41-60Yrs)
5.845200E-01
Normal-vs-Age(61-80Yrs)
7.882400E-01
Normal-vs-Age(81-100Yrs)
4.947400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.589000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.364400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.561200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.108960E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.796000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.402000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.498600E-01
Normal-vs-Daily Drinker
5.242800E-01
Normal-vs-Weekly Drinker
9.384400E-01
Normal-vs-Occasional Drinker
8.755700E-02
Normal-vs-Social Drinker
5.086800E-01
Non Drinker-vs-Daily Drinker
1.743980E-01
Non Drinker-vs-Weekly Drinker
4.095400E-01
Non Drinker-vs-Occasional Drinker
3.032200E-01
Non Drinker-vs-Social Drinker
8.946800E-01
Daily Drinker-vs-Weekly Drinker
3.330400E-01
Daily Drinker-vs-Occasional Drinker
3.61819999999957E-05
Daily Drinker-vs-Social Drinker
2.144200E-02
Weekly Drinker-vs-Occasional Drinker
2.784400E-03
Weekly Drinker-vs-Social Drinker
1.850430E-01
Occasional Drinker-vs-Social Drinker
2.008200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.602000E-01
Normal-vs-Grade 2
3.003200E-01
Normal-vs-Grade 3
4.298000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.811600E-01
Grade 1-vs-Grade 3
9.580200E-02
Grade 1-vs-Grade 4
3.602000E-01
Grade 2-vs-Grade 3
1.828960E-01
Grade 2-vs-Grade 4
3.003200E-01
Grade 3-vs-Grade 4
4.298000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.916600E-01
Normal-vs-NonDiabetic
6.710600E-01
Diabetic-vs-NonDiabetic
3.051900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.867600E-01
Normal-vs-NoPancreatitis
7.218000E-01
Pancreatitis-vs-NoPancreatitis
5.059800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.801000E-01
Normal-vs-N1
7.825800E-01
N0-vs-N1
2.694400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.601000E-01
Normal-vs-TP53-NonMutant
6.018400E-01
TP53-Mutant-vs-TP53-NonMutant
3.620900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
